Modulari-T

We teach your immune system to attack and cure cancer

Montreal, Canada · Founded 2021

Headquarters
Montreal
Employees
1–10
Founded
2021
Last Round
Pre-SeedMay 2023
Rounds
1

About

Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.

Summary

Modulari-T is a Biotech company based in Montreal, Canada, founded in 2021. Its most recent funding was a Pre-Seed round in May 2023. Investors include Y Combinator, Metaplanet and Pioneer Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-SeedMay 2023

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Modulari-T on Indexed.vc
<a href="https://indexed.vc/companies/modulari-t-bio"><img src="https://indexed.vc/api/badge/company/modulari-t-bio" alt="Modulari-T on Indexed.vc" width="260" height="76" /></a>